This study demonstrates that when it comes to drug therapy, Americans are appropriately concerned with an increasing number of drug-related adverse events, Fendrick said.
"Yet, before we put in place a new level of regulation to ensure greater safety for prescription drugs, it is important to weigh the health gains from the use of these [drugs] against the documented risks before judgment can be made," Fendrick said. "As should be the case of all the things we do as doctors, both the risks and benefits of pharmaceuticals should be carefully evaluated."
For more on drug safety, visit the U.S. Food and Drug Administration.
SOURCES: James Thurber, Ph.D., director, Center for Congressional and Presidential Studies, American University, Washington, D.C.; A. Mark Fendrick, M.D., professor, internal medicine, University of Michigan School of Medicine, and professor, health management and policy, University of Michigan School of Public Health, Ann Arbor; Sept. 19, 2007, news release, Consumers Union; Sept. 20, 2007, Prescription Drug Safety: National Survey
All rights reserved